Position in NVS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$699,441
+$278,615 QoQ
Shares Held
4,463
+62.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#752
of 1,603 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Indivisible Partners holds $35,776,309 across 12 Drug Manufacturers - General names. NVS ranks #9 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,876 | $16,643,292 | |
| 2 | JNJ |
Johnson & Johnson
|
25,301 | $6,425,694 | |
| 3 | ABBV |
AbbVie Inc.
|
12,876 | $3,240,116 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,859 | $2,294,881 | |
| 5 | AZN |
Astrazeneca PLC
|
8,421 | $1,596,790 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
11,373 | $1,436,864 | |
| 7 | PFE |
Pfizer Inc
|
46,671 | $1,123,837 | |
| 8 | AMGN |
Amgen Inc
|
3,073 | $1,112,794 |
All Filings in NVS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $699,441 | 4,463 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $420,826 | 2,755 | Shares | Sole | 2026-04-30 | |
| No filing history on record for this holder in this stock. | ||||||